Reuters -- Drug developer Depomed Inc said it filed a lawsuit in a U.S. federal court against India’s Lupin Ltd alleging that Lupin’s application to market a generic version of Depomed’s diabetes drug Glumetza infringed its patents.
Reuters -- Drug developer Depomed Inc said it filed a lawsuit in a U.S. federal court against India’s Lupin Ltd alleging that Lupin’s application to market a generic version of Depomed’s diabetes drug Glumetza infringed its patents.
